Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

著者: Karim Fizazi, Michael A. Carducci, Matthew R. Smith, Ronaldo Damião, Janet E. Brown, Lawrence I. Karsh, Piotr Milecki, Neal D. Shore, Michael Rader, Huei Wang, Qi Jiang, Sylvia Tadros, Roger Dansey, Carsten Goessl - The Lancet 2011 被引用: 1,965